Publication | Closed Access

Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug–drug interaction in HIV patients

Drug InteractionsPharmacologyAntiviral Drug DevelopmentAntiviral TherapyHiv PatientsPharmacotherapyAntiviral DrugHivMedicineAntiviral CompoundPotential Drug–drug InteractionDrug DiscoveryDrug Resistance